Raymond James Maintains Strong Buy on Alignment Healthcare, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom has reaffirmed a Strong Buy rating on Alignment Healthcare (NASDAQ:ALHC) and increased the price target from $10 to $12.

January 09, 2024 | 10:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst John Ransom maintains a Strong Buy rating on Alignment Healthcare and raises the price target to $12.
The increase in price target by Raymond James is a positive signal to investors, suggesting a bullish outlook on Alignment Healthcare's stock. This could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100